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Correction
The authors would like to apologize for failing to attri-
bute text in their manuscript [1]. The following sentences
were not referenced correctly as a direct quotation:
"Ras protein is activated transiently as a response to
extracellular signals, such as growth factors, cytokines,
and hormones that stimulate cell surface receptors. It can
switch between an inactive state, in which the proteins
are bound to guanosine-diphosphates, and an active
state, in which conversion to guanosine- triphosphate
(GTP) occurs. Mutant activated forms of Ras proteins
have an impaired intrinsic GTPase activity, which renders
the protein resistant to inactivation by regulatory
GTPase-activating proteins" [2].
In addition, the following errors were made in the
Abstract, paragraph 2 of the Results and Table two of the
original publication [1]:
1. The methods described in the Abstract as "poly-
merase chain reaction-single strand conformational poly-
morphism" should be "polymerase chain reaction and
Sanger sequencing".
2.The sentence in the Results (paragraph 2) "leading to
substitution of a glutamine by leucine acid (Gln849Leu)"
should be replaced by "leading to substitution of a Lysine
by Arginine (Lys728Arg)." The sentence "leading to tran-
sitions of Lys728Arg and Ala871Thr." should be "leading
to transitions of Gln849Leu and Ala871Thr."
3.In the EGFR column of Table two of the original pub-
lication, Gln849Leu in the first row should be replaced by
Lys728Arg. In the second row of the same column,
Lys728Arg should be replaced by Gln849Leu. The correc-
tions are shown in Table 1.
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Page 2 of 2Table 1: Corrections to Table two "Epidermal growth factor receptor and K-ras mutations"
Site Wild type Type of point mutation Number of mutations (%) Amino acid Heterozygous/homozygous
EGFRa Exon 18 AAG 2183A>G 1 (33.3) Lys728Arg Heterozygous
Exon 21 CAG 2546A>T 1 (33.3) Gln849Leu Heterozygous
Exon 21 GCA 2611G>A 1 (33.3) Ala871Thr Heterozygous
K-ras Codon 12 GGT 35G>A 16 (47.1) Gly12Asp Heterozygous
Codon 12 GGT 34G>T 6 (17.6) Gly12Cys Heterozygous
Codon 12 GGT 34G>A 3 (8.8) Gly12Ser Heterozygous
Codon 12 GGT 34G>A 1 (2.9) Gly12Ser Homozygous
Codon 12 GGT 34G>T 1 (2.9) Gly12Cys Homozygous
Codon 12 GGT 35G>C 1 (2.9) Gly12Ala Heterozygous
Codon 12 GGT 35G>A 1 (2.9) Gly12Asp Homozygous
Codon 12 GGT 35G>T 1 (2.9) Gly12Val Heterozygous
Codon 13 GGC 38G>A 1 (2.9) Gly13Asp Heterozygous
Codon 45 GTA 133G>A 1 (2.9) Val45Ile Homozygous
Codon 69 GAC 205G>A 1 (2.9) Asp69Asn Homozygous
Codon 80 TGT 239G>A 1 (2.9) Cys80Tyr Heterozygous
Corrections to Table 2 "Epidermal growth factor receptor and K-ras mutations" in the original publication [1] are shown in Table 1 of this 
Correction as follows: In the EGFR column of Table 2, Gln849Leu in the first row should be replaced by Lys728Arg. In the second row of the EGFR 
column, Lys728Arg should be replaced by Gln849Leu, as shown in Table 1 of this Correction.
